^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

pogalizumab (MOXR0916)

i
Other names: MOXR0916, RG7888, MOXR 0916, MOXR-0916, RG-7888, RG 7888, RO7021608
Associations
Trials
Company:
Roche
Drug class:
OX40 agonist
Associations
Trials